Brainstorm Cell Therapeutics Inc (BCLI) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Brainstorm Cell Therapeutics inc   (BCLI)

Brainstorm Cell Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BCLI Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 72.95 % 67.33 % 46.1 %
Gross Margin (Q2 TTM) - 77.91 % 67.32 % 46.43 %
Gross Profit Margin 5 Yr. Avg. - 71.08 % 65.62 % 48.97 %
EBITDA Margin (Q2 MRQ) - 5.89 % 17.59 % 20.44 %
EBITDA Margin (Q2 TTM) - 16.74 % 19.89 % 20.05 %
EBITDA Margin 5 Yr. Avg. - 22.84 % 23.7 % 23.02 %
Operating Margin (Q2 MRQ) - -0.63 % 16.01 % 16.07 %
Operating Margin (Q2 TTM) - 7.14 % 17.58 % 16.37 %
Operating Margin 5 Yr. Avg. - 6.06 % 14.35 % 19.27 %
Pre-Tax Profit Margin (Q2 MRQ) - -2.73 % 10.24 % 13.99 %
Pre-Tax Profit Margin (Q2 TTM) - 9.01 % 12.18 % 13.1 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.91 % 10.39 % 13.52 %
Net Margin (Q2 MRQ) - -8.53 % 7.58 % 11.44 %
Net Margin (Q2 TTM) - 5.14 % 9.46 % 10.6 %
Net Margin 5 Yr. Avg. - 6.61 % 6.09 % 10.81 %